Hyperbaric Therapy and Autism Ranking:

Additional Information

Every few years, the European Committee for Hyperbaric Medicine (ECHM) publishes its recommendations concerning the clinical indications for hyperbaric oxygen therapy (HBOT).  According to Kot J. Mathieu D. (2011) who wrote the most recent recommendations:

“Currently there is no clear rationale for HBOT in autism based on clinically proven pathophysiological mechanisms. The few studies on the use of pressurised environments (not always compatible with the definition of ‘hyperbaric oxygen therapy’) for autism have serious methodological limitations. Therefore, autism should remain as a non-accepted indication for HBOT. HBOT should be used only within the framework of an ethically approved clinical trial.”

Related Additional Information

• Hyperbaric Therapy

Updated

17 Jun 2022

Last Review

01 Sep 2016

Next Review

01 Dec 2022